flag igf2bp2 Search Results


n terminal flag tag  (Sino Biological)
90
Sino Biological n terminal flag tag
RBM3 interacts with IMP2. a Representative immunofluorescent staining of RBM3 and IMP2 in SVZ-NSPCs and SGZ-NSPCs from adult WT mouse brain. RBM3 (red), IMP2 (green) and DAPI (blue) were merged. Scale bar: 25 µm. b Representative immunofluorescent images from proximity ligation assay. SVZ-NSPCs and SGZ-NSPCs were challenged with OGD and reoxygenated for 3 h. WT NSPCs omitting primary antibodies (WT NC) or KO NSPCs served as negative controls (KO NC). Fluorescent dots indicating single RBM3-IMP2 interactions were counted in each cell, and 25 cells per group were used for quantification ( n = 25). RBM3-IMP2 PLA signals (red) and DAPI (blue) were merged. Scale bar: 25 µm. Two-way ANOVA was used for statistical analysis; n.s. not significant; ** p < 0.01; *** p < 0.001; **** p < 0.0001. All data are presented as mean ± SEM. c Representative image of proximity ligation assay of RBM3 and IMP2 in frozen brain sections from adult mice treated with HI and 7 days recovery. Scale bar: 50 µm. Contra contralateral (uninjured side), ipsi ipsilateral (injured side), LV lateral ventricle, cc corpus callosum, GCL granular cell layer, NC negative control without primary antibodies. d Schematic illustration of RBM3 and IMP2 constructs. Full-length (FL) RBM3 was fused with an <t>N-terminal</t> HA tag. Full-length (FL) IMP2 was truncated to N-terminal domain with two RNA-recognition motifs (RRMs) or C-terminal domain with four K Homology motifs (KHs); all of the constructs included an N-terminal <t>FLAG</t> tag. e , f Representative co-immunoprecipitation graphs of full-length or truncated RBM3 and IMP2 in HEK293 cells. Full-length FLAG-IMP2 was co-overexpressed with vector (Vec, negative control), or HA-RBM3 with or without RNase T1 pre-treatment. FLAG antibody was used to precipitate FLAG-IMP2. FLAG-IMP2 and HA-RBM3 in input or IP samples were detected by anti-FLAG or anti-HA antibodies using Western blot ( e ). A reciprocal CoIP was performed using full-length HA-RBM3 to precipitate full-length FLAG-IMP2, FLAG-RRMs or FLAG-KHs ( f ). Asterisks indicate target bands. HC heavy chain of IgG used for immunoprecipitation, LC light chain of IgG used for immunoprecipitation. g Representative Western blot of IMP2 expression in SVZ-NSPC and SGZ-NSPC after mock or OGD treatment in the presence or absence of RBM3
N Terminal Flag Tag, supplied by Sino Biological, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/flag+igf2bp2/pmc06726629-323-10-13?v=Sino+Biological
Average 90 stars, based on 1 article reviews
n terminal flag tag - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
human igf2bp2 imp2 gene orf cdna clone expression plasmid c flag tag  (Sino Biological)
N/A
Full length Clone DNA of Human insulin like growth factor 2 mRNA binding protein 2 with C terminal Flag tag
   Buy from Supplier

Image Search Results


RBM3 interacts with IMP2. a Representative immunofluorescent staining of RBM3 and IMP2 in SVZ-NSPCs and SGZ-NSPCs from adult WT mouse brain. RBM3 (red), IMP2 (green) and DAPI (blue) were merged. Scale bar: 25 µm. b Representative immunofluorescent images from proximity ligation assay. SVZ-NSPCs and SGZ-NSPCs were challenged with OGD and reoxygenated for 3 h. WT NSPCs omitting primary antibodies (WT NC) or KO NSPCs served as negative controls (KO NC). Fluorescent dots indicating single RBM3-IMP2 interactions were counted in each cell, and 25 cells per group were used for quantification ( n = 25). RBM3-IMP2 PLA signals (red) and DAPI (blue) were merged. Scale bar: 25 µm. Two-way ANOVA was used for statistical analysis; n.s. not significant; ** p < 0.01; *** p < 0.001; **** p < 0.0001. All data are presented as mean ± SEM. c Representative image of proximity ligation assay of RBM3 and IMP2 in frozen brain sections from adult mice treated with HI and 7 days recovery. Scale bar: 50 µm. Contra contralateral (uninjured side), ipsi ipsilateral (injured side), LV lateral ventricle, cc corpus callosum, GCL granular cell layer, NC negative control without primary antibodies. d Schematic illustration of RBM3 and IMP2 constructs. Full-length (FL) RBM3 was fused with an N-terminal HA tag. Full-length (FL) IMP2 was truncated to N-terminal domain with two RNA-recognition motifs (RRMs) or C-terminal domain with four K Homology motifs (KHs); all of the constructs included an N-terminal FLAG tag. e , f Representative co-immunoprecipitation graphs of full-length or truncated RBM3 and IMP2 in HEK293 cells. Full-length FLAG-IMP2 was co-overexpressed with vector (Vec, negative control), or HA-RBM3 with or without RNase T1 pre-treatment. FLAG antibody was used to precipitate FLAG-IMP2. FLAG-IMP2 and HA-RBM3 in input or IP samples were detected by anti-FLAG or anti-HA antibodies using Western blot ( e ). A reciprocal CoIP was performed using full-length HA-RBM3 to precipitate full-length FLAG-IMP2, FLAG-RRMs or FLAG-KHs ( f ). Asterisks indicate target bands. HC heavy chain of IgG used for immunoprecipitation, LC light chain of IgG used for immunoprecipitation. g Representative Western blot of IMP2 expression in SVZ-NSPC and SGZ-NSPC after mock or OGD treatment in the presence or absence of RBM3

Journal: Nature Communications

Article Title: RBM3 promotes neurogenesis in a niche-dependent manner via IMP2-IGF2 signaling pathway after hypoxic-ischemic brain injury

doi: 10.1038/s41467-019-11870-x

Figure Lengend Snippet: RBM3 interacts with IMP2. a Representative immunofluorescent staining of RBM3 and IMP2 in SVZ-NSPCs and SGZ-NSPCs from adult WT mouse brain. RBM3 (red), IMP2 (green) and DAPI (blue) were merged. Scale bar: 25 µm. b Representative immunofluorescent images from proximity ligation assay. SVZ-NSPCs and SGZ-NSPCs were challenged with OGD and reoxygenated for 3 h. WT NSPCs omitting primary antibodies (WT NC) or KO NSPCs served as negative controls (KO NC). Fluorescent dots indicating single RBM3-IMP2 interactions were counted in each cell, and 25 cells per group were used for quantification ( n = 25). RBM3-IMP2 PLA signals (red) and DAPI (blue) were merged. Scale bar: 25 µm. Two-way ANOVA was used for statistical analysis; n.s. not significant; ** p < 0.01; *** p < 0.001; **** p < 0.0001. All data are presented as mean ± SEM. c Representative image of proximity ligation assay of RBM3 and IMP2 in frozen brain sections from adult mice treated with HI and 7 days recovery. Scale bar: 50 µm. Contra contralateral (uninjured side), ipsi ipsilateral (injured side), LV lateral ventricle, cc corpus callosum, GCL granular cell layer, NC negative control without primary antibodies. d Schematic illustration of RBM3 and IMP2 constructs. Full-length (FL) RBM3 was fused with an N-terminal HA tag. Full-length (FL) IMP2 was truncated to N-terminal domain with two RNA-recognition motifs (RRMs) or C-terminal domain with four K Homology motifs (KHs); all of the constructs included an N-terminal FLAG tag. e , f Representative co-immunoprecipitation graphs of full-length or truncated RBM3 and IMP2 in HEK293 cells. Full-length FLAG-IMP2 was co-overexpressed with vector (Vec, negative control), or HA-RBM3 with or without RNase T1 pre-treatment. FLAG antibody was used to precipitate FLAG-IMP2. FLAG-IMP2 and HA-RBM3 in input or IP samples were detected by anti-FLAG or anti-HA antibodies using Western blot ( e ). A reciprocal CoIP was performed using full-length HA-RBM3 to precipitate full-length FLAG-IMP2, FLAG-RRMs or FLAG-KHs ( f ). Asterisks indicate target bands. HC heavy chain of IgG used for immunoprecipitation, LC light chain of IgG used for immunoprecipitation. g Representative Western blot of IMP2 expression in SVZ-NSPC and SGZ-NSPC after mock or OGD treatment in the presence or absence of RBM3

Article Snippet: Commercial pCMV3-IMP2 plasmid was designed for full-length IMP2 overexpression with N-terminal FLAG tag (Sino Biological, HG11116-NF).

Techniques: Staining, Proximity Ligation Assay, Negative Control, Construct, FLAG-tag, Immunoprecipitation, Plasmid Preparation, Western Blot, Expressing